Overview
ALVO market data
Price History
ALVO price chart
Valuation & Profitability
- P/E (TTM)
- 44.19 Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
- Forward P/E
- — P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
- EPS (TTM)
- $0.10 Diluted earnings per share over the trailing twelve months.
- Beta
- 0.22 Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
- Dividend Yield
- — Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
- Profit Margin
- — Net income divided by revenue. Comparable within a sector, less so across sectors.
- 52w range
- $2.94 – $9.94 Lowest and highest closing prices over the past 52 weeks.
- Analyst Target
- — Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.
Display-only. Refreshed once per symbol per 24 hours · source Twelve Data /statistics · market cap $1.2K · P/S 2.20.
Company news
Viðskipti stjórnenda og tengdra aðilaGlobenewswire Inc · Jul 3, 2026, 9:15 PM
Transactions of Managers and Closely Associated PersonsGlobenewswire Inc · Jul 3, 2026, 9:15 PM
Dave and Buster's Reports Downbeat Q1 Earnings, Joins Alvotech And Other Big Stocks Moving Lower In Tuesday's Pre-Market SessionBenzinga · Jun 16, 2026, 12:10 PM
Alvotech Commences ~$125M Offering Of Ordinary SharesBenzinga · Jun 15, 2026, 8:25 PM
Teva's Biosimilar Boom Is Just Getting Started. Is It Time to Buy This Rebounding Pharma Stock?The Motley Fool · Jun 12, 2026, 9:15 PM